MAGIA

MAGIA, The European MedTech Alliance dedicated to supporting the internationalization of SMEs, brings together 4 poles of excellence:  Lyonbiopôle (France), BioPmed (Italy), BioWin and Life Science Nord (Germany), and aims to achieve a solid and reciprocal understanding of the activities of the four clusters in order to strengthen their collaboration. In this context, each...
Read More

S3MARTMED

For the cluster, S3MartMed constitutes an opportunity to develop a partnership with 4 other European clusters of excellence - BioPmed (Italy), BioRegio STERN Management (Germany), Lyonbiopôle (France) and MedSilesia (Poland) - in order to identify in the medical technology sector: Future key investment priorities, Joint activities for the emergence of interregional collaborations (commercial...
Read More

JOIN T-AIC

Development of new therapeutic approaches for the treatment of inflammatory mono-arthritis combining “novel” anti-TNF-α and viscoelastic scaffold Mono-arthritis is generally treated by intra-articular injections of corticosteroids or of hyaluronic acid. However, due to their limited efficacy, or due to their toxicity, injectable corticosteroids are only administered a few times, which...
Read More

Deep

Drug-releasing electrode with enhanced properties This project is about the development of an implantable electrode with quantitative drug eluting capacity. Polypyrrole coating of platinum nanostructuresformsthe basis of thisinnovative technology. Two lines of application are foreseen: one is to exploit the release of an anti-inflammatory drug in order to limit the...
Read More

Brainµ

Bacteria and Resistance to Antibiotics. Identification using Nanotechnology and Microfluidics The goal of this project is to develop an in vitro test to identify the pathogenic bacteria and resistance parameters to antibiotics commonly encountered in human bacteremia. Doctors need a quick test to define the rapidly the most adequate therapy....
Read More

Targetum

Chitosan-based Targeting Drug Delivery Systems (Cs-tDDS) and their Proof of Concept Today, the most efficient therapeutic approaches in cancer rely on targeting the tumoral cells in order to enhance the therapeutic effect of the drug, to decrease its dosage and to limit its side effects. The TARGETUM Project aims at...
Read More

Valostem

Development of new cell-based in vitro models for ADME/Toxicity screening, based on human adult progenitor/stem cells Characterization of a new drug candidate during preclinical evaluation includes, in addition to potency and safety an assessment of drug metabolism and pharmacokinetics. Drug metabolism studies require identification ofthe products of drug candidate metabolism,...
Read More

Rheumagene

Development of a new diagnostic method of arthritis The aim of this project is to validate the diagnostic value of transcriptomic and/or proteomic profiles of synovial material in early arthritis. It is based on preliminary data showing that gene expression profilesin synovial biopsiesfrom patients with arthritis are able to discriminate...
Read More

VapChip

Bacterial resistance assay in real time PCR on array for patients with Ventilator Associated Pneumonia (VAP) The aim of the project is a pre-validation of a new real time assay (VAP-technology) for the rapid detection of the bacterial species and their resistance in pneumonia. The assay was developed in order...
Read More